Regenerative Medicine

World Market Report

MCP-1241

EXECUTIVE ENGAGEMENTS

POOL

13706
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1643
Interactions with Platform & by Email

PARTICIPANTS

411
Unique # Participated

VALIDATIONS

86
Responses Validated*

COMPANIES

52
Responses Validated*
* Login for a full stack data experience

DATE

JAN 2023

TABLES

122

PAGES

198

EDITION

19

PRICE

USD 5450

CODE

MCP-1241


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

RANK

(S/A/N/T)

%

VALIDATED RESEARCH *

* S = Strong; A = Active; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
RESEARCH MODULES EXECUTIVES
  

HIGHLIGHTS & REPORT INDEX

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
»Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
»Online interactive peer-to-peer collaborative bespoke updates
»Access to our digital archives and MarketGlass Research Platform
»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Regenerative Medicine Market to Reach $30.8 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Regenerative Medicine estimated at US$9.6 Billion in the year 2022, is projected to reach a revised size of US$30.8 Billion by 2030, growing at a CAGR of 15.8% over the analysis period 2022-2030. Cell Therapy, one of the segments analyzed in the report, is projected to record a 16.3% CAGR and reach US$15.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Gene Therapy segment is readjusted to a revised 15.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $2.8 Billion, While China is Forecast to Grow at 14.7% CAGR
The Regenerative Medicine market in the U.S. is estimated at US$2.8 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.2 Billion by the year 2030 trailing a CAGR of 14.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.4% and 13.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 11.2% CAGR.

SELECT PLAYERS

AlloSource; Anika Therapeutics, Inc.; Bioventus LLC; DePuy Synthes Spine, Inc.; Exactech, Inc.; Integra LifeSciences Holdings Corp.; LifeNet Health, Inc.; Medtronic, PLC; NovaBone Products LLC; NuVasive, Inc.; Orthofix International N.V.; Osiris Therapeutics, Inc.; Smith & Nephew plc; Stryker Corporation; Wright Medical Technology, Inc.; Zimmer Biomet Holdings, Inc.

SEGMENTS

» Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, Other Product Types) » Material Type (Biologically Derived, Synthetic, Genetically Engineered, Other Material Types) » Application (Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology, Other Applications)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Regenerative Medicine: A Preface
Recent Market Activity
An Overview of Regenerative Medicine in Bone and Joint Applications
Current and Future Analysis
Developed Markets Dominate, Developing to Drive Growth
Regenerative Medicine - Past, Present & Future
Another Revolution in the Making?
Conventional Chemical Medicine Vs Regenerative Medicine
Regenerative Medicine - Bypassing the Ethical Concerns
Regenerative Medicine Throws Up Several New Therapies
Current Global Market for Regenerative Medicine
Market Potential
Therapeutic Companies and Products in Regenerative Medicine - Current Status
Regenerative Medicine – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for 52 Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
AlloSource (US)
Anika Therapeutics, Inc. (US)
Bioventus LLC (US)
DePuy Synthes Companies (US)
DePuy Synthes Spine, Inc. (US)
Exactech, Inc. (US)
Integra LifeSciences Holdings Corp. (US)
LifeNet Health, Inc. (US)
Medtronic, plc (Ireland)
NovaBone Products LLC (US)
NuVasive, Inc. (US)
Orthofix International N.V. (Netherlands)
Osiris Therapeutics, Inc. (US)
Smith & Nephew plc (UK)
Stryker Corporation (US)
Wright Medical Technology, Inc. (US)
Zimmer Biomet Holdings, Inc. (US)
3. MARKET TRENDS & DRIVERS
A Combination of Factors to Drive Regenerative Medicine Market
Burgeoning Global Population Offers Significant Growth Opportunities
Aging Global Population: Need for New Effective Treatments
Increasing Healthcare Spending in Emerging Markets: Opportunities in Store
Government Support and Increased Private Sector Participation
Investment and Funding Landscape
Major M&A Activity and Strategic Alliances in Regenerative Medicine: 2011-2016
Recent Advancements in the Science of Regenerative Medicine
Advanced Ceramics Gaining Preeminence in Regenerative Medicine Field
3D Organ & Tissue Printing: Still in Early Stages
Nanotechnology in Regenerative Medicine
Issues to be Sorted Out
Need for New Scientific and Technological Standards
Standardized Guidelines
Clinical Translation - Collaboration of Multidisciplinary Skills is Essential
The Question of Apt Business Models - The Service and Product Approach
Autologous or Service Approach Preferred by European Firms
Allogenic or Product Approach - Slow to Develop
Regenerative Medicine Requires Improved Biomaterials
Investors Wary of Funding Regenerative Medicine
Regenerative Medicine Field Lags Behind Due to Segregated Focus
Challenges Encountered by Regenerative Medicine
Scientific and Technological Challenges
Barriers in Sharing Intellectual Property Rights
Viable Manufacturing Technologies and Skilled Personnel Crucial
Strict Regulations Push up Operational Costs
Challenges Facing Autologous Cell Therapies
4. GLOBAL MARKET PERSPECTIVE
World Recent Past, Current & Future Analysis for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
World Historic Review for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
World 16-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
World Recent Past, Current & Future Analysis for Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
World Historic Review for Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
World 16-Year Perspective for Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
World Recent Past, Current & Future Analysis for Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
World Historic Review for Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
World 16-Year Perspective for Gene Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
World Recent Past, Current & Future Analysis for Tissue Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
World Historic Review for Tissue Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
World 16-Year Perspective for Tissue Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
World 16-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
World Recent Past, Current & Future Analysis for Biologically Derived by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
World Historic Review for Biologically Derived by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
World 16-Year Perspective for Biologically Derived by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
World Recent Past, Current & Future Analysis for Synthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
World Historic Review for Synthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
World 16-Year Perspective for Synthetic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
World Recent Past, Current & Future Analysis for Genetically Engineered by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
World Historic Review for Genetically Engineered by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
World 16-Year Perspective for Genetically Engineered by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
World Recent Past, Current & Future Analysis for Other Material Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
World Historic Review for Other Material Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
World 16-Year Perspective for Other Material Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
World Recent Past, Current & Future Analysis for Musculoskeletal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
World Historic Review for Musculoskeletal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
World 16-Year Perspective for Musculoskeletal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
World 16-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
World Recent Past, Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
World Historic Review for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
World 16-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
World Recent Past, Current & Future Analysis for Dermatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
World Historic Review for Dermatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
World 16-Year Perspective for Dermatology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
World Recent Past, Current & Future Analysis for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
World Historic Review for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
World 16-Year Perspective for Ophthalmology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
World Regenerative Medicine Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
UNITED STATES
Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
USA Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
USA Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
USA 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
USA Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
USA Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
USA 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
USA Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
USA Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
USA 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030
CANADA
Canada Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Canada Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Canada 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
Canada Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Canada Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Canada 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
Canada Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Canada Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Canada 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030
JAPAN
Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
Japan Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Japan Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Japan 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
Japan Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Japan Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Japan 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
Japan Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Japan Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Japan 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030
CHINA
Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
China Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
China Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
China 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
China Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
China Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
China 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
China Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
China Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
China 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030
EUROPE
Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
Europe Recent Past, Current & Future Analysis for Regenerative Medicine by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Europe Historic Review for Regenerative Medicine by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Europe 16-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
Europe Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Europe Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Europe 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
Europe Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Europe Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Europe 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
Europe Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Europe Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Europe 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030
FRANCE
Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
France Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
France Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
France 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
France Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
France Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
France 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
France Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
France Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
France 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030
GERMANY
Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
Germany Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Germany Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Germany 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
Germany Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Germany Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Germany 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
Germany Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Germany Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Germany 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030
ITALY
Italy Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Italy Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Italy 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
Italy Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Italy Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Italy 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
Italy Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Italy Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Italy 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030
UNITED KINGDOM
Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
UK Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
UK Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
UK 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
UK Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
UK Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
UK 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
UK Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
UK Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
UK 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Rest of Europe Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Rest of Europe 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
Rest of Europe Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Rest of Europe Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Rest of Europe 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
Rest of Europe Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Rest of Europe Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Rest of Europe 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030
ASIA-PACIFIC
Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
Asia-Pacific Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Asia-Pacific Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Asia-Pacific 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
Asia-Pacific Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Asia-Pacific Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Asia-Pacific 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
Asia-Pacific Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Asia-Pacific Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Asia-Pacific 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030
REST OF WORLD
Rest of World Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Rest of World Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Rest of World 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
Rest of World Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Rest of World Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Rest of World 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
Rest of World Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Rest of World Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Rest of World 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com